- Home
- SDSTW vs VRAX Comparison
SDSTW vs VRAX Comparison
Compare SDSTW & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDSTW
- VRAX
- Stock Information
- Founded
- SDSTW N/A
- VRAX 2013
- Country
- SDSTW United States
- VRAX United Kingdom
- Employees
- SDSTW 8
- VRAX N/A
- Industry
- SDSTW
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SDSTW
- VRAX Health Care
- Exchange
- SDSTW Nasdaq
- VRAX Nasdaq
- Market Cap
- SDSTW 3.8M
- VRAX 4.4M
- IPO Year
- SDSTW N/A
- VRAX 2022
- Fundamental
- Price
- SDSTW $0.05
- VRAX $0.57
- Analyst Decision
- SDSTW
- VRAX Strong Buy
- Analyst Count
- SDSTW 0
- VRAX 1
- Target Price
- SDSTW N/A
- VRAX $3.00
- AVG Volume (30 Days)
- SDSTW 41.6K
- VRAX 1.4M
- Earning Date
- SDSTW 03-26-2025
- VRAX 01-01-0001
- Dividend Yield
- SDSTW N/A
- VRAX N/A
- EPS Growth
- SDSTW N/A
- VRAX N/A
- EPS
- SDSTW N/A
- VRAX N/A
- Revenue
- SDSTW N/A
- VRAX $6,331.00
- Revenue This Year
- SDSTW N/A
- VRAX $217,274.83
- Revenue Next Year
- SDSTW N/A
- VRAX N/A
- P/E Ratio
- SDSTW N/A
- VRAX N/A
- Revenue Growth
- SDSTW N/A
- VRAX N/A
- 52 Week Low
- SDSTW $0.10
- VRAX $0.52
- 52 Week High
- SDSTW $0.12
- VRAX $4.44
- Technical
- Relative Strength Index (RSI)
- SDSTW N/A
- VRAX 30.37
- Support Level
- SDSTW N/A
- VRAX $0.56
- Resistance Level
- SDSTW N/A
- VRAX $0.65
- Average True Range (ATR)
- SDSTW 0.00
- VRAX 0.05
- MACD
- SDSTW 0.00
- VRAX -0.01
- Stochastic Oscillator
- SDSTW 0.00
- VRAX 15.95
About SDSTW Stardust Power Inc. Warrant
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).